| |
EDVI (ml/m2.7)
|
ESVI (ml/m2.7)
|
LVMI (g/m2.7)
|
EF (%)
|
|---|
|
Total
|
1,991
|
31.7 ± 6.6
|
9.9 ± 3.9
|
36.7 ± 8.4
|
69 ± 8
|
|
Sex
|
Female
|
1,034
|
31.6 ± 6.1
|
8.9 ± 2.9
|
35.1 ± 7.6
|
72 ± 6
|
|
Male
|
957
|
31.7 ± 7.1
|
10.8 ± 4.5
|
38.4 ± 8.8
|
66 ± 8
|
|
Ethnicity
|
White1
|
739
|
30.6 ± 6.2
4
|
9.7 ± 3.4
2,4
|
35.2 ± 7.2
2,3,4
|
67 ± 7
2
|
|
Chinese2
|
356
|
30.1 ± 5.0
3,4
|
8.4 ± 2.5
1,3,4
|
33.1 ± 6.3
1,3,4
|
72 ± 6
1,3,4
|
|
Black3
|
405
|
31.8 ± 7.3
2,4
|
10.4 ± 4.5
2
|
38.4 ± 9.5
1,2
|
68 ± 8
2
|
|
Hispanic4
|
491
|
34.4 ± 6.7
1,2,3
|
10.8 ± 4.3
1,2
|
39.9 ± 8.9
1,2
|
69 ± 8
2
|
|
Smoking
|
Never1
|
1,053
|
31.8 ± 6.1
|
9.5 ± 3.3
3
|
35.9 ± 7.7
3
|
70 ± 7
2,3
|
|
Former2
|
682
|
31.5 ± 7.1
|
10.1 ± 4.3
|
37.1 ± 9.0
|
68 ± 8
1
|
|
Current3
|
249
|
32.0 ± 7.2
|
10.7 ± 4.3
1
|
38.3 ± 9.0
1
|
67 ± 7
1
|
|
Alcohol
|
Never1
|
490
|
31.3 ± 5.8
|
9.0 ± 3.1
2,3
|
35.4 ± 7.7
2
|
72 ± 7
2,3
|
|
Former2
|
492
|
31.8 ± 7.2
|
10.0 ± 4.3
1
|
37.5 ± 8.9
1
|
69 ± 8
1
|
|
Current3
|
990
|
31.9 ± 6.7
|
10.2 ± 3.9
1
|
36.8 ± 8.4
|
68 ± 7
1
|
|
Hypertension
|
No
|
1,135
|
31.2 ± 6.3
|
9.9 ± 3.6
|
34.8 ± 7.2
|
69 ± 7
|
|
Yes
|
856
|
32.3 ± 7.0
|
9.8 ± 4.2
|
39.1 ± 9.2
|
70 ± 8
|
|
Diabetes
|
Normal1
|
1,444
|
31.6 ± 6.5
|
9.8 ± 3.6
|
35.8 ± 7.9
2,3,4
|
69 ± 7
|
|
Impaired fasting glucose2
|
285
|
31.6 ± 6.3
|
9.7 ± 3.7
|
37.8 ± 8.3
1
|
70 ± 8
|
|
Untreated diabetes3
|
58
|
33.0 ± 6.8
|
11.0 ± 4.0
|
40.9 ± 10.9
1
|
67 ± 9
|
|
Treated diabetes4
|
203
|
32.5 ± 7.7
|
10.3 ± 5.4
|
40.2 ± 9.4
1
|
69 ± 9
|
- Significant differences by ANOVA (p < 0.005) are highlighted in bold-face. Scheffé’s multiple-comparison post-hoc tests are represented by super-indices indicating differences between the labeled sub-cohorts at an α-level of 0.005 (when significant differences were found in categorical variables).
